This section of the website is for UK healthcare professionals only. If you are not a healthcare professional, please click here.
This section of the website is for UK healthcare professionals only. If you are not a healthcare professional, please click here.

Prof Tom Powles summarises KEYNOTE-045 clinical trial

Prescribing Information

KEYTRUDA® (pembrolizumab)

Prescribing Information

Length: 04:25

Prof Tom Powles, shares his thoughts and talks though the KEYNOTE-045 phase 3 trial of pembrolizumab vs chemotherapy (paclitaxel, docetaxel or vinflunine) in patients with locally advanced or metastatic urothelial cancer.

More information about KEYTRUDA:

Supporting documentation

GB-PDO-01005 | Date of Preparation: June 2020